Improve The Input-output Efficiency Research Of H Pharmaceutical R&Dcompany

In China,the pharmaceutical industry is the main industry that integrates traditional industry and modern industry,and plays a key role in the development and overall promotion of China's national economy.Its particularity is reflected in its direct relationship with the daily life of Chinese people.With the continuous development of economy and society,as a small and medium-sized innovative enterprise,independent innovation ability is the key factor for the company to master the core ability and maintain the efficient core competitiveness,and it has become an important means for the company to carry out technological innovation research and development activities.Under the background of deepening economic globalization,Chinese pharmaceutical companies are in urgent need of upgrading and reforming the technology from the source to realize the sustainable development of Chinese pharmaceutical companies.Selection in this paper,we study the case of the H pharmaceutical r-esearch and development company,the enterprise strategy theory input-output theory and related data,combining with 2014-2018 the company's research and development input and output data analysis comparison,the basis of literature analysis,ease study,the H pharmaceutical company's research and development input and output status,will H pharmaceutical company's research and development spending of the constitution and the quality of the spending,research and development personnel and new drug patent results,combining corporate profitability,and to research and development situation and existing problems of input and output management specific analysis,This paper studies how the economic and human resources iriput of research and development affect the growth performance of the company,and from the perspective of the company,summarizes and analyzes the solutions and enlightenment of the problem.Meanwhile,based on the research of H pharmaceutical research and development company,it provides method support for the continuous improvement of the overall research and development level of China's pharmaceutical industry.Innovation of this paper:1.Targeted case study.Can be found from the analysis of research status at home and abroad,the pharmaceutical companies to develop the research input and output is less,and more on the whole situation of the pharmaceutical industry as a starting point,carries on the analysis,this paper is targeted the choice of case study,the more prominent in small innovative r&d input and output characteristics of pharmaceutical companies.2.Prospective evaluation of developmental countemmeasures.In this paper about the research and development of small and medium-sized enterprise investment and enterprise performance of the relationship between the various theoretical literature and generalizes the research achievement.found only in problem analysis and put forward countermeasures,to the developmental countermeasures of estimate is less,this article is the combination of innovative cases of actual were evaluated,increases the overall r-esearch value.